← Back to Search

Visible Light Phototesting for Skin Health

N/A

Waitlist Available

Research Sponsored by Henry Ford Health System

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up visit 4 (day 14)

Awards & highlights

Study Summary

This trial will measure how different light and UV sources affect skin, including redness, pigmentation, and damage.

Who is the study for?

This trial is for healthy adults over 18 with any skin type, who haven't been in strong sun recently. They must understand the study and not take certain meds or use new skin products during the trial. It's not for those prone to heavy bleeding, allergic to specific anesthetics, have a history of abnormal scarring, are pregnant/lactating/planning pregnancy, using photosensitizing drugs or treatments that affect results.Check my eligibility

What is being tested?

The study tests two types of visible light solar simulators on skin: one closer to natural sunlight (VL+UVA1) and another standard version (VL+UVA1). The goal is to see how different light compositions affect biological responses like redness and pigmentation changes in various skin types.See study design

What are the potential side effects?

Potential side effects may include immediate or delayed redness of the skin (erythema), changes in skin coloration (pigmentation), and signs of photodamage due to exposure to the light sources used in this research.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ visit 4 (day 14)

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~visit 4 (day 14)

This trial's timeline: 3 weeks for screening, Varies for treatment, and visit 4 (day 14) for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Erythema assessment

Erythema assessment for 14 participants

Erythema assessment for all 14 participants

+7 more

Secondary outcome measures

Immunohistochemical changes in pigmentation, inflammation, and profileration, for all 14 participants

RNA sequencing for 8 participants

Trial Design

1Treatment groups

Experimental Treatment

Group I: VL+UVA1Experimental Treatment2 Interventions

Participants will be treated with VL + UVA1 light source

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Henry Ford Health SystemLead Sponsor

300 Previous Clinical Trials

2,099,985 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any opportunities to participate in the trial at this juncture?

"Affirmative, the clinical trial is open for recruitment and data hosted on clinicaltrials.gov attests to this fact. The study was first released on October 6th 2021 and modified two years later, with 14 patients required from one medical centre."

Answered by AI

What is the size of the population involved in this research endeavor?

"Affirmative. Noted on clinicaltrials.gov, this medical study is currently recruiting subjects. It was initially advertised on October 6th 2021 and the details have been refreshed as of September 21st 2023. A total of 14 individuals must be recruited at 1 participating centre for successful completion of the experiment."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Optimizing Phototesting and Investigating Photobiology of Visible Light

Indermeet Kohli 2021. "Optimizing Phototesting and Investigating Photobiology of Visible Light". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05964907.